Company / Revenue
AtriCure, Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$534.5M
FY2025
5-year range
$274.3M / $534.5M
FY2021-FY2025
Trend
+14.9%
vs FY2024
Sector context
#115 of 150
Health Care
What the data says
AtriCure, Inc.'s revenue of $535M is lower than 77% of companies in the Health Care sector (FY2025). Revenue has increased for 5 consecutive years, from $207M in FY2020 to $535M in FY2025.
Based on SEC 10-K filings.
$535M in FY2025 with a 5-year CAGR of +20.9%.
Improved from $399M to $535M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +17.4%
- 5-Year CAGR
- +20.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 150This company $534.5M Sector average $19.5B
▼
-97.3% below sector average
Key checks
Key Insights
- AtriCure, Inc.'s revenue has grown for 5 consecutive years.
- 5-year CAGR of +20.9%, indicating consistent growth.
- In FY2025, revenue increased 14.9% year-over-year.
- Ranks #115 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -9.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $534.5M | +14.9% |
| FY2024 | $465.3M | +16.5% |
| FY2023 | $399.2M | +20.8% |
| FY2022 | $330.4M | +20.4% |
| FY2021 | $274.3M | +32.8% |
| FY2020 | $206.5M | -10.5% |
| FY2019 | $230.8M | +14.5% |
| FY2018 | $201.6M | +15.4% |
| FY2017 | $174.7M | +12.6% |
| FY2016 | $155.1M | +19.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026